ArticleCancer medicine2023

Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.

Matthew W Parsons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.